DEAZAPURINNUCLEOSID KOMPOSITIONER INEHOLDENDE DETTE OG FREMGANGSMAADE TIL FREMSTILLING AF SAADANNE KOMPOSITIONER

The use of 3-deazaadenosine, 4-amino-1- beta -D-ribofuranosyl-1H-imidazo-[4,5-c] pyridine, for the treatment of inflammation in mammals, including man, is disclosed. Pharmaceutical formulations suitable for administration of the compound, in particular topical formulations for local application, are...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VINEGAR R, WOLBERG G
Format:	Patent
Sprache:	dan
Schlagworte:	CASTING CASTING OF METALS CASTING OF OTHER SUBSTANCES BY THE SAME PROCESSES OR DEVICES CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PERFORMING OPERATIONS POWDER METALLURGY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS TRANSPORTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The use of 3-deazaadenosine, 4-amino-1- beta -D-ribofuranosyl-1H-imidazo-[4,5-c] pyridine, for the treatment of inflammation in mammals, including man, is disclosed. Pharmaceutical formulations suitable for administration of the compound, in particular topical formulations for local application, are also disclosed.